About
ProCore Bio Med is a biotechnology company focused on developing solutions to improve the quality of life for patients suffering from joint and bone diseases. The company's flagship RegenoGel family of products is based on proprietary HAProLink technology, which links hyaluronic acid to a protein to create a microenvironment for natural cartilage and bone regeneration. ProCore operates a cGMP-, ISO 9001:2008- and ISO13485:2016-accredited cell therapy facility and has extensive experience producing clinical grade products. Procore was established in 2008 and has headquarters, production facilities and R&D laboratories in the Weizmann Science Park in central Israel. Procore Bio wishes to become a global leader in the Regenerative Medicine arena, aiming to provide solutions and enhance quality of life through biomimetic innovation.
Headcount over time
Q&A
- What is ProCore Bio Med's primary focus?
- ProCore Bio Med is a biotechnology company focused on developing cost-effective solutions for bone and cartilage regeneration, utilizing proprietary scaffolds, growth factors, and stem or progenitor cells.
- What is ProCore Bio Med's flagship product for osteoarthritis?
- ProCore Bio Med's flagship product is RegenoGel, a highly stable viscosupplement gel designed to treat osteoarthritis by preserving joints and regenerating cartilage. It is based on the company's proprietary HAProLink technology.
- What kind of technology platform does ProCore Bio Med utilize?
- ProCore Bio Med's technology platform includes various biomaterials, such as hyaluronic acid-based injectable hydrogels, proprietary growth factors with enhanced activity, and protocols for stem and progenitor cell isolation, expansion, and differentiation.
- When was ProCore Bio Med founded?
- ProCore Bio Med was founded in September 2008.
- Where is ProCore Bio Med headquartered?
- ProCore Bio Med is headquartered in Ness Ziona, Center District, Israel.
- What is the employee count for ProCore Bio Med?
- ProCore Bio Med has 1-10 employees.
- Who is the Founder and CEO of ProCore Bio Med?
- Prof. Avner Yayon is the Founder and CEO of ProCore Bio Med.
- Has ProCore Bio Med been involved in any consortiums?
- Yes, ProCore Bio Med has been a principal member of the Genesis consortium, the Israeli consortium for stem cell therapy.
- What is the current product stage of ProCore Bio Med?
- ProCore Bio Med's product is currently released.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | regenogel.co.il/ |
|---|---|
| facebook.com/RegenoGelProcore |
Identifiers & details
| Legal name | PROCORE LTD |
|---|---|
| Founded | 2008-9 |
| Employees (exact) | 6 |
Radar intelligence
Web history (Wayback)
| Domain | regenogel.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514180892 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2008-09-01 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | גולדה מאיר 7 נס ציונה |